GlamBud™ will identify prospective community members using metrics, available subscription lists and public relations events. Those identified will be solicited with a personal invitation for a ‘no-risk’ trial.  It is anticipated that with rich, balanced content and promotional offerings, GlamBud will activate and engage over one million aesthetics patients in the US by 2022.
Stay In Touch
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram